Reset Map3 Results
17 rue du fort Huningue, Grand Est, 68330 FranceFiralis Molecular Precision provides to its customers a broad range of omics technologies to help them scale by increasing their analytical capacities in the most flexible and customizable way. We are a certified service provider for Olink Explore HT, Target 96/48 and Flex running the Target 48 and Flex in GCLP mode. Firalis Molecular Precision is the preferred partner for patient’s sample management thanks to a strong expertise in protocol design, biobanking, and multidimensional samples analysis. Whether it is in the patient's perspective for diagnostic, prognostic, prediction and monitoring of the disease progression; or from the drug’s perspective to evaluate toxicity and efficiency. Beyond its multi-omic approach, analytical capacities and scientific expertise, Firalis group is an end-to-end partner which offers clinical qualification, biobanking infrastructure, assay development, bioanalytical testing, data analysis and production facilities to empower your team and fasten your projects. Genomics: Firalis Molecular Precision is a French high throughput sequencing center equipped with the latest Illumina X Plus platform, NextSeq 2000 and NovaSeq 6000Dx. We provide all the platforms and experts required to perform genomic and transcriptomic analysis from DNA/RNA extraction to qPCR or DNA/RNA sequencing according to your requirements in terms of price, sensibility, analytes and acquisition time. In addition, the cutting-edge single cell analysis system brings powerful oncological section analysis, allowing study and characterization of the Tumor Microenvironment on a cell-by-cell basis. Our company offers a complete range of genomic analysis including detection of SNPs, CNVs, variants, ctDNA, gene identification, species identification, and genome structural organization. About transcriptomic, we provide whole transcriptomes to targeted sequencing analysis, allowing identification of novel transcripts, alternative splicing and differential gene transcription quantification. The characterization of rare cell types and biomarkers is also assessed on a cell-by-cell basis. Proteomics: When it comes to proteomic, our scientific team offers a large panel of services, ranging from large screening and new drug target discovery (Olink Explore HT, Explore 3072 and Explore 384) to target validation and monitoring with Olink Target 48/Flex; Luminex, MSD or ELLA to the extremely sensitive technologies such as the Quanterix SR-X and SP-X. More than a hundred of analytes are already validated on our platforms. Firalis group is certified ISO 13485 (GMP compliant) and ISO 9001 for the development and production of CE-marked assays, certified ISO20287 for its biobank and accredited CAP for testing laboratory, including NGS and genotyping. Lab staff is trained GCLP and we are ISO14001 for environmental management.
35 rue du fort 68330 Huningue, 68330 FranceFiralis Molecular Precision provides to its customers a broad range of omics technologies to help them scale by increasing their analytical capacities in the most flexible and customizable way. We are a certified service provider for Olink Explore HT, Target 96/48 and Flex running the Target 48 and Flex in GCLP mode. Firalis Molecular Precision is the preferred partner for patient’s sample management thanks to a strong expertise in protocol design, biobanking, and multidimensional samples analysis. Whether it is in the patient's perspective for diagnostic, prognostic, prediction and monitoring of the disease progression; or from the drug’s perspective to evaluate toxicity and efficiency. Beyond its multi-omic approach, analytical capacities and scientific expertise, Firalis group is an end-to-end partner which offers clinical qualification, biobanking infrastructure, assay development, bioanalytical testing, data analysis and production facilities to empower your team and fasten your projects. Genomics: Firalis Molecular Precision is a French high throughput sequencing center equipped with the latest Illumina X Plus platform, NextSeq 2000 and NovaSeq 6000Dx. We provide all the platforms and experts required to perform genomic and transcriptomic analysis from DNA/RNA extraction to qPCR or DNA/RNA sequencing according to your requirements in terms of price, sensibility, analytes and acquisition time. In addition, the cutting-edge single cell analysis system brings powerful oncological section analysis, allowing study and characterization of the Tumor Microenvironment on a cell-by-cell basis. Our company offers a complete range of genomic analysis including detection of SNPs, CNVs, variants, ctDNA, gene identification, species identification, and genome structural organization. About transcriptomic, we provide whole transcriptomes to targeted sequencing analysis, allowing identification of novel transcripts, alternative splicing and differential gene transcription quantification. The characterization of rare cell types and biomarkers is also assessed on a cell-by-cell basis. Proteomics: When it comes to proteomic, our scientific team offers a large panel of services, ranging from large screening and new drug target discovery (Olink Explore HT, Explore 3072 and Explore 384) to target validation and monitoring with Olink Target 48/Flex; Luminex, MSD or ELLA to the extremely sensitive technologies such as the Quanterix SR-X and SP-X. More than a hundred of analytes are already validated on our platforms. Firalis group is certified ISO 13485 (GMP compliant) and ISO 9001 for the development and production of CE-marked assays, certified ISO20287 for its biobank and accredited CAP for testing laboratory, including NGS and genotyping. Lab staff is trained GCLP and we are ISO14001 for environmental management.
17 rue du fort 68330 Huningue, 68330 FranceFiralis Molecular Precision provides to its customers a broad range of omics technologies to help them scale by increasing their analytical capacities in the most flexible and customizable way. We are a certified service provider for Olink Explore HT, Target 96/48 and Flex running the Target 48 and Flex in GCLP mode. Firalis Molecular Precision is the preferred partner for patient’s sample management thanks to a strong expertise in protocol design, biobanking, and multidimensional samples analysis. Whether it is in the patient's perspective for diagnostic, prognostic, prediction and monitoring of the disease progression; or from the drug’s perspective to evaluate toxicity and efficiency. Beyond its multi-omic approach, analytical capacities and scientific expertise, Firalis group is an end-to-end partner which offers clinical qualification, biobanking infrastructure, assay development, bioanalytical testing, data analysis and production facilities to empower your team and fasten your projects. Genomics: Firalis Molecular Precision is a French high throughput sequencing center equipped with the latest Illumina X Plus platform, NextSeq 2000 and NovaSeq 6000Dx. We provide all the platforms and experts required to perform genomic and transcriptomic analysis from DNA/RNA extraction to qPCR or DNA/RNA sequencing according to your requirements in terms of price, sensibility, analytes and acquisition time. In addition, the cutting-edge single cell analysis system brings powerful oncological section analysis, allowing study and characterization of the Tumor Microenvironment on a cell-by-cell basis. Our company offers a complete range of genomic analysis including detection of SNPs, CNVs, variants, ctDNA, gene identification, species identification, and genome structural organization. About transcriptomic, we provide whole transcriptomes to targeted sequencing analysis, allowing identification of novel transcripts, alternative splicing and differential gene transcription quantification. The characterization of rare cell types and biomarkers is also assessed on a cell-by-cell basis. Proteomics: When it comes to proteomic, our scientific team offers a large panel of services, ranging from large screening and new drug target discovery (Olink Explore HT, Explore 3072 and Explore 384) to target validation and monitoring with Olink Target 48/Flex; Luminex, MSD or ELLA to the extremely sensitive technologies such as the Quanterix SR-X and SP-X. More than a hundred of analytes are already validated on our platforms. Firalis group is certified ISO 13485 (GMP compliant) and ISO 9001 for the development and production of CE-marked assays, certified ISO20287 for its biobank and accredited CAP for testing laboratory, including NGS and genotyping. Lab staff is trained GCLP and we are ISO14001 for environmental management.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.